Philippens IH - Search Results

1

Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.

van Helden HP, Joosen MJ, Philippens IH. van Helden HP, et al. Among authors: philippens ih. Toxicol Lett. 2011 Sep 25;206(1):35-40. doi: 10.1016/j.toxlet.2011.04.021. Epub 2011 Apr 28. Toxicol Lett. 2011. PMID: 21554933 Review.

2

Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs.

Philippens IH, Joosen MJ, Vanwersch RA. Philippens IH, et al. Pharmacol Biochem Behav. 2005 Sep;82(1):125-32. doi: 10.1016/j.pbb.2005.07.018. Epub 2005 Aug 26. Pharmacol Biochem Behav. 2005. PMID: 16126267

3

Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects.

van Vliet SA, Vanwersch RA, Jongsma MJ, van der Gugten J, Olivier B, Philippens IH. van Vliet SA, et al. Among authors: philippens ih. Behav Pharmacol. 2006 Sep;17(5-6):453-62. doi: 10.1097/00008877-200609000-00011. Behav Pharmacol. 2006. PMID: 16940766

4

Therapeutic effects of Delta9-THC and modafinil in a marmoset Parkinson model.

van Vliet SA, Vanwersch RA, Jongsma MJ, Olivier B, Philippens IH. van Vliet SA, et al. Among authors: philippens ih. Eur Neuropsychopharmacol. 2008 May;18(5):383-9. doi: 10.1016/j.euroneuro.2007.11.003. Epub 2008 Jan 28. Eur Neuropsychopharmacol. 2008. PMID: 18222654

5

Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease.

Verhave PS, Vanwersch RA, van Helden HP, Smit AB, Philippens IH. Verhave PS, et al. Among authors: philippens ih. Behav Brain Res. 2009 Jun 8;200(1):214-9. doi: 10.1016/j.bbr.2009.01.022. Behav Brain Res. 2009. PMID: 19378465

6

Neurofeedback training on sensorimotor rhythm in marmoset monkeys.

Philippens IH, Vanwersch RA. Philippens IH, et al. Neuroreport. 2010 Mar 31;21(5):328-32. doi: 10.1097/WNR.0b013e3283360ba8. Neuroreport. 2010. PMID: 20186109

7

REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease.

Verhave PS, Jongsma MJ, Van den Berg RM, Vis JC, Vanwersch RA, Smit AB, Van Someren EJ, Philippens IH. Verhave PS, et al. Among authors: philippens ih. Sleep. 2011 Aug 1;34(8):1119-25. doi: 10.5665/SLEEP.1174. Sleep. 2011. PMID: 21804674 Free PMC article.

8

Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.

Verhave PS, Jongsma MJ, Van Den Berg RM, Vanwersch RA, Smit AB, Philippens IH. Verhave PS, et al. Among authors: philippens ih. Neuropharmacology. 2012 Mar;62(4):1700-7. doi: 10.1016/j.neuropharm.2011.11.016. Epub 2011 Dec 8. Neuropharmacology. 2012. PMID: 22178201

9

Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model.

Philippens IH, Joosen MJ, Ahnaou A, Andres I, Drinkenburg WP. Philippens IH, et al. Behav Brain Res. 2014 Aug 1;269:81-6. doi: 10.1016/j.bbr.2014.04.028. Epub 2014 Apr 24. Behav Brain Res. 2014. PMID: 24769173 Free article.

10

Individual and Familial Susceptibility to MPTP in a Common Marmoset Model for Parkinson's Disease.

Franke SK, van Kesteren RE, Hofman S, Wubben JA, Smit AB, Philippens IH. Franke SK, et al. Among authors: philippens ih. Neurodegener Dis. 2016;16(5-6):293-303. doi: 10.1159/000442574. Epub 2016 Mar 22. Neurodegener Dis. 2016. PMID: 26999593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters